Showing results (141-150 of 246) with videos related to
Sort By:
Pageof 25
Psychopharmacology|February 2, 2002
Chromium treatment decreases the sensitivity of 5-HT2A receptorsM-J Attenburrow, J Odontiadis, B J Murray, et al.Psychopharmacology|July 4, 2001
Low-dose citalopram as a 5-HT neuroendocrine probeM J Attenburrow, P R Mitter, R Whale, et al.Psychopharmacology|June 27, 2000
Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramineR Whale, D J Quested, D Laver, et al.Psychopharmacology|January 1, 1997
Sumatriptan decreases food intake and increases plasma growth hormone in healthy womenS Boeles, C Williams, G M Campling, et al.Translational Psychiatry|November 23, 2016
Early changes in emotional processing as a marker of clinical response to SSRI treatment in depressionB R Godlewska, M Browning, R Norbury, et al.Journal of Psychopharmacology (Oxford, England)|January 30, 2007
A single dose of citalopram increases fear recognition in healthy subjectsM Browning, C Reid, P J Cowen, et al.Psychological Medicine|November 1, 1988
Binding of tritiated yohimbine to platelets in women with maternity bluesN R Best, M Wiley, K Stump, et al.British Journal of Pharmacology|June 1, 1982
beta-Adrenoceptor agonists enhance 5-hydroxytryptamine-mediated behavioural responsesP J Cowen, D G Grahame-Smith, A R Green, et al.Lancet (London, England)|August 21, 1982
Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responsesD W Costain, P J Cowen, M G Gelder, et al.British Journal of Clinical Pharmacology|June 1, 1985
Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmissionP J Cowen, A R Green, D G Grahame-Smith, et al.Pageof 25